Vir Biotechnology is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies.
We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best.
Vir Biotechnology is looking for an experienced communicator with strong biopharma scientific knowledge to join our biotech company as the Sr. Director of R&D Communications. Reporting to the SVP, Corporate Communications, this pivotal role is responsible for translating complex scientific information into clear, compelling messages for a variety of communication assets and audiences. You will lead efforts to establish and maintain scientific thought leadership, collaborate closely with patient advocacy and external communications, as well as Vir Bio’s Chief Scientific Officer (CSO) and Chief Medical Officer (CMO), to drive impactful communication strategies that elevate the company's profile in the biopharma industry.
This role is located in our San Francisco headquarters with an expectation of at least 3 days per week in office.
WHAT YOU'LL DO- Translate complex scientific concepts into accessible and engaging content for diverse audiences, ensuring clear understanding of our research and development initiatives
- Develop and manage strategies to establish and enhance scientific thought leadership within the R&D team and the broader organization
- Identify and capitalize on scientific thought leadership opportunities with the goal of positioning Vir Bio as a leader in the biopharma industry
- Work with patient advocacy to incorporate patient perspectives into the R&D objectives, ensuring consistent messaging and brand representation
- Lead and facilitate the dissemination of R&D updates to all stakeholders, utilizing various communication platforms and tactics
- Gain insights into the rapidly evolving biopharma industry and stay abreast of advancements in research and development
- Support our CSO and CMO with internal and external engagement preparations
- Coordinate with leaders across the organization to align R&D communications with overall corporate objectives
- Identify and facilitate thought leadership opportunities for Vir Bio leaders that highlight both their own and our expertise
- Advanced degree in a relevant scientific discipline
- Minimum of 15 years of experience in communications, with a focus on translating scientific information for diverse audiences
- Biotech or pharmaceutical industry experience required
- Passion for storytelling around novel and transformative science and therapeutic candidates
- Extremely strong verbal, written, and presentation communication skills with a track record of presenting to and coaching senior company leaders
- Experience driving strategic scientific thought leadership opportunities
- Demonstrated ability to develop and execute strategic communication plans that align with organizational goals
- Strong network and relationships with influencers in the scientific and healthcare community
The expected salary range for this position is $227,500.00 to $318,000.00. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors.
Vir Biotechnology's compensation and benefits are aligned with the current market and commensurate with the person’s experience and qualifications. All full-time employees receive a package that includes compensation, bonus and equity as well as many other Vir Biotechnology benefits and perks such as health and welfare benefit plans, non-accrual paid time off, company shut down for holidays, commuter benefits, childcare reimbursement, education reimbursement, 401K match and lunch each day in the office.
Applicants must currently be authorized to work for any employer in the U.S. We are unable to sponsor or take over sponsorship of an employment Visa at this time.
All employment decisions at Vir Biotechnology are based on legitimate, non-discriminatory business requirements, job duties and individual qualifications. Employment decisions are made without regard to any legally protected characteristics.
This commitment extends to all management practices and decisions, including recruitment and hiring, compensation, appraisal systems, promotions, training and career development programs. Vir Biotechnology also strongly commits to providing employees with a work environment free of unlawful conduct or harassment.
Vir Biotechnology Human Resources leads recruitment and employment for Vir Biotechnology. Unsolicited resumes sent to the company from recruiters do not constitute any type of relationship between the recruiter and Vir Biotechnology and do not obligate us to pay fees should we hire from those resumes. We ask that external recruiters and/or agencies not contact or present candidates directly to our hiring manager or employees.
For hires based in the United States, Vir Biotechnology, participates in E-Verify.
Candidate Privacy Notice
What We Do
Vir Biotechnology, Inc. (in Europe, Humabs BioMed, https://bit.ly/46lQGN2) is an immunology company focused on powering the immune system to address unmet patient needs in infectious disease and beyond. Our powerful R&D engine combines our proprietary monoclonal antibody (mAb) platform with machine learning and artificial intelligence-enhanced capabilities, enabling us to engineer our rich database of human antibodies and deliver transformative medicines for diseases with significant global burden.
Our current pipeline consists of multiple clinical candidates targeting hepatitis B and hepatitis delta viruses and human immunodeficiency virus, including a potential functional cure for chronic hepatitis B and treatment for chronic hepatitis delta. Our portfolio of broad, potent investigational monoclonal antibodies also targets influenza A and B viruses, COVID-19, respiratory syncytial virus/human metapneumovirus and human papillomavirus, and our investigational T cell vaccine aims to prevent HIV. Explore our full pipeline: https://bit.ly/3tr7FPm
We collaborate with some of the world’s leaders in industry as well as government agencies and non-profit organizations enabling us to rapidly advance cutting-edge scientific discoveries and innovative technologies with the potential to benefit people around the world.
We are proud to have been ranked the fastest-growing company in North America on the 2022 Deloitte Technology Fast 500™.
Join us as we pursue our mission to transform lives.
It has come to our attention that there have been various recruitment scams targeting job seekers on LinkedIn. Vir Biotechnology, Inc. is committed to your privacy and will never request sensitive personal information including banking details through email, text message, social media or video software platforms. We also will never request a financial commitment from a candidate as part of the application process. Learn more about Vir’s recruiting process: https://bit.ly/461EgJN
